These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Opinion: anticipating change in drug development: the emerging era of translational medicine and therapeutics. Fitzgerald GA. Nat Rev Drug Discov; 2005 Oct; 4(10):815-8. PubMed ID: 16224453 [Abstract] [Full Text] [Related]
3. Redefining cancer research. Alberts B. Science; 2009 Sep 11; 325(5946):1319. PubMed ID: 19745119 [No Abstract] [Full Text] [Related]
4. [Front-line drug discovery system for cancer]. Mizukami T. Gan To Kagaku Ryoho; 2008 Dec 11; 35(13):2293-300. PubMed ID: 19098393 [Abstract] [Full Text] [Related]
7. [Development for and clinical trials of molecular targeting drugs]. Takashima A, Fukuda H, Shibata T. Gan To Kagaku Ryoho; 2010 May 11; 37(5):822-7. PubMed ID: 20524257 [No Abstract] [Full Text] [Related]
10. Institutional profile: Developing and evaluating new drugs for cancer treatment: perspectives from the US National Cancer Institute. Trimble EL, Abrams JS, Ansher SS, Smith MA, Zwiebel JA, Tomaszewski JE. Future Med Chem; 2010 Apr 11; 2(4):555-9. PubMed ID: 21426005 [No Abstract] [Full Text] [Related]
19. American Society of Clinical Oncology--43rd annual meeting. Research into therapeutics: Part 2. Walker K. IDrugs; 2007 Aug 15; 10(8):517-9. PubMed ID: 17665321 [No Abstract] [Full Text] [Related]